According to Iterum Therapeutics's latest financial reports the company's current EPS (TTM) is -$6.47. In 2022 the company made an earnings per share (EPS) of -$4.81 an increase over its 2021 EPS that were of -$16.52.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$6.12 | 27.31% |
2022 | -$4.81 | -70.88% |
2021 | -$16.52 | -72.13% |
2020 | -$59.27 | -61.18% |
2019 | -$152.69 | 16.48% |
2018 | -$131.09 | 57.64% |
2017 | -$83.16 |